Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045942
Status:
COMPLETED
Last Update Posted:
2017-08-11
First Post:
2002-09-16
Brief Title:
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome CPKC412A2104 Core and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 FLT3 CPKC412A2104E1 and CPKC412A2104E2
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2008-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2002-09-16
First Submit QC Date:
September 17 2002
Study First Post Date:
2002-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-07
Last Update Post Date:
2017-08-11
Last Update Post Date Type:
ACTUAL